| Effect | Decrease |
| Trial Design | Cohort |
| Trial Length | 2-4 Weeks |
| Number of Subjects | 16 |
| Sex | Both Genders |
| Age Range | 45-64 |
| Body Types | Overweight |
Supplementation of colostrum in type II diabetics at 5g (no placebo; colostrum around 25% immunoglobulins by weight and mostly IgG) for four weeks on an empty stomach appeared to reduce fasting blood glucose by 10-14% relative to baseline and also reduced lipid panels and blood ketone concentrations.
